From The Economic Times
Center-Right Owned by Bennett, Coleman & Co.Mankind Pharma shares key business developments from Q2 & H1 of FY27
RSS excerpt
The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of 18.7% and 15.8%, respectively. In acute therapies, gastroenterology grew at 1.3 times the market rate, while vitamins, minerals and nutrients (VMN) expanded at…
